SCOTT M ROCKLAGE
CIK 1219014 · last filed 2024-03-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$66.54M
Companies
14
Total Filings
29
Lifetime Open-Market Net
$11.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RLYB | 10%+ Owner | 1,251,755 | $15.92 | $19.93M | -$19.72M | 2 | 2023-03-09 |
| Pear Therapeutics, Inc. (PEARW) Delisted | 10%+ Owner | 537,406 | $0.01 | $3.2K | -$2.31M | 1 | 2022-11-15 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 3,153,331 | $13.29 | $41.91M | -$50.76M | 1 | 2020-12-31 |
| APRE | Director | 75,965 | $0.69 | $52.1K | -$20.01M | 5 | 2020-07-01 |
| CABA | 10%+ Owner | 3,214,721 | $3.01 | $9.68M | $35.00M | 1 | 2019-10-31 |
| IDYA | 10%+ Owner | 84,420 | $28.98 | $2.45M | $37.50M | 1 | 2019-05-28 |
| ARVN | 10%+ Owner | 4,512,136 | $7.58 | $34.20M | -$30.68M | 1 | 2019-04-01 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Director | — | $221.38 | — | $0 | 4 | 2018-06-15 |
| scPharmaceuticals Inc. (SCPH) Delisted | 10%+ Owner | 103,945 | $5.67 | $589.4K | $55.00M | 1 | 2017-11-21 |
| PULM | Director | 168,873 | $1.40 | $236.4K | $266.8K | 4 | 2016-02-25 |
| EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Director | 2,549,211 | — | — | $2.00M | 2 | 2015-06-08 |
| VIVEVE MEDICAL, INC. (TCON) Delisted | 10%+ Owner | 7,310,231 | $0.03 | $235.4K | $1.50M | 1 | 2015-05-29 |
| Achaogen, Inc. (AKAO) Delisted | Director | — | — | — | $0 | 1 | 2014-03-13 |
| Relypsa Inc (RLYP) Delisted | Director | 2,258,376 | — | — | $4.10M | 2 | 2013-11-20 |
Recent Filings · Page 2 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-10-31 | CABA | Mixed | +25,684,862 | $35.00M | EDGAR |
| 2019-10-07 | APRE | Conv (C) | +2,506,650 | $0 | EDGAR |
| 2019-05-28 | IDYA | Mixed | +15,730,955 | $37.50M | EDGAR |
| 2019-04-01 | ARVN | Sell (S) | −2,166,774 | -$30.68M | EDGAR |
| 2018-06-15 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-21 | scPharmaceuticals Inc. (SCPH) Delisted | Mixed | +19,520,622 | $55.00M | EDGAR |
| 2017-06-23 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-24 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-25 | PULM | Grant (A) | — | $0 | EDGAR |
| 2015-06-25 | PULM | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.